CDMO Activity Tracker: Lupin’s CDMO commissions oncology block in India; Cambrex, Axplora, Hovione expand operations

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

NEVARAPINE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 18 USDMF, 11 CEP/COS, 1 JDMF, 4 EU WC, 9 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

22 Drugs in Development

22 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

158 FDF Dossiers, 60 FDA Orange Book, 52 Europe, 4 Canada, 2 Australia, 26 South Africa, 14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 400MG, TABLET;ORAL - 150MG;200MG;300MG, TABLET;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 4 DKSH, 6 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 ACG Worldwide, 1 Actylis, 1 Aeon Procare, 1 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 11 BASF, 10 Corel Pharma Chem, 7 DFE Pharma, 7 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 4 Pharmatrans-Sanaq, 5 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders, 37 Coating Systems & Additives, 31 Direct Compression, 28 Disintegrants & Superdisintegrants, 27 Granulation, 21 Lubricants & Glidants, 19 Controlled & Modified Release, 16 Thickeners and Stabilizers, 12 Co-Processed Excipients, 10 Solubilizers, 8 Taste Masking, 8 Chewable & Orodispersible Aids, 8 Film Formers & Plasticizers, 6 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 3 Parenteral, 2 Coloring Agents

DIGITAL CONTENT

11 News #PharmaBuzz

11 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 19 Regulatory FDF Prices

MARKET PLACE

8 APIs, 6 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 2 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 2 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
29/11/2025	Arch Pharmalabs	India	ARCH PHARMALABS LTD	22162	NEVIRAPINE ANHYDROUS USP	2008-11-05	Inactive	II	N/A
29/11/2025	Aurobindo Pharma Limited	India	APITORIA PHARMA PRIVATE LTD	18401	NEVIRAPINE HEMIHYDRATE USP	2005-05-22	Active	II	N/A

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

NEVARAPINE

NEVARAPINE

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers

18 USDMF

11 CEP/COS

1 JDMF

4 EU WC

9 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

22 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

158 FDF Dossiers

60 FDA Orange Book

52 Europe

4 Canada

2 Australia

26 South Africa

14 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 100MG

TABLET, EXTENDED RELEASE;ORAL - 400MG

TABLET;ORAL - 150MG;200MG;300MG

TABLET;ORAL - 200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION;ORAL - 50MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem

5 SPI Pharma

4 DKSH

6 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 ACG Worldwide

1 Actylis

1 Aeon Procare

1 Alcedo Pharmachem

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

11 BASF

10 Corel Pharma Chem

7 DFE Pharma

7 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

4 Ideal Cures

4 Ingredion Pharma Solutions

23 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

13 Microlex e.U

3 Nitika Pharmaceutical Specialities

3 Novo Excipients

4 Pharmatrans-Sanaq

5 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

16 Roquette

7 Seppic

6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

11 Sigachi Industries

4 Silverline Chemicals

2 The Dow Chemical Company

1 Ulanqab Kema New Material

4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

58 Fillers, Diluents & Binders

37 Coating Systems & Additives

31 Direct Compression

28 Disintegrants & Superdisintegrants

TABLET;ORAL - 200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons